Puerarin ameliorates nonalcoholic fatty liver in rats by regulating hepatic lipid accumulation, oxidative stress, and inflammation
Emerging therapies show promise for those who don't respond to current GLP-1 medications
Most individuals find 0.1 to 0.15 mg daily sufficient for chronic condition management
95 (Suppl
Inadequate secretion of intrinsic factor, resulting from lesions that destroy the gastric mucosa (which can be caused by ingestion of corrosives, extensive tumors, and conditions associated with gastric atrophy, such as multiple sclerosis, certain endocrine disorders, iron deficiency, and subtotal gastrectomy) Structural lesions leading to vitamin B 12 deficiency, including regional ileitis, ileal reactions, and malignancies Competition for vitamin B 12 by intestinal parasites or bacteria
Understanding B12 treatments phases and how long it lasts helps doctors tailor therapy for each patient